@Scott_Wiener I imagine the concern there is probably that having subcritical levels of PrEP in the blood supply could increase the prevalence of drug-resistant strains of HIV https://t.co/r2Kfd2hbxB
@Bear4Blackxxx @brucewaynesabtm https://t.co/OEALWRLlqD Evidence provided. As we study more and in time get more information the numbers will change, just like with any other medication. I'm not saying prep is bad I'm saying infections do occur and will ov
@islandofcovid @crawlsonrocks @KayLKelley @Gab_H_R Evidence suggests selection for HIV drug resistance with PrEP use is infrequent & most likely to occur when PrEP is used during undiagnosed acute HIV infection.Breakthrough infections during PrEP use w
RT @sspa_daniel: Estos temas dan mucho que hablar y es necesario formar a los profesionales. Cada vez nos encontramos más dudas como esta e…
Estos temas dan mucho que hablar y es necesario formar a los profesionales. Cada vez nos encontramos más dudas como esta en las consultas médicas y de enfermería y no sabemos responder! 😓
Check out our findings about HIV antiretroviral resistance & PrEP use in our latest paper: https://t.co/Pb191Ylw0a
RT @DeptPopMed: New pub from @KevinGibasMD, @DeptPopMed's Doug Krakower, et al finds the benefit of decreased HIV incidence w/wider #PrEP u…
New pub from @KevinGibasMD, @DeptPopMed's Doug Krakower, et al finds the benefit of decreased HIV incidence w/wider #PrEP use is likely to outweigh the risk of harms from possible increases in the prevalence of HIV drug resistance: https://t.co/9p5df2tr7b